About this trial
The risk of atherosclerotic cardiovascular disease is increased in people with HIV infection, including young patients and those with few traditional cardiovascular risk factors. The increased risk of cardiovascular disease among people living with HIV is due to accelerated atherosclerosis, caused by chronic inflammation and immune dysregulation. The measurement of coronary calcium using plain computed tomography is a subclinical indicator of coronary atherosclerosis and is associated with the risk of cardiovascular events and mortality in the general population.
Eligibility criteria
Qualifiers
Patients who have been diagnosed with HIV infection for more than 6 months
Undetectable viral load
Disqualifiers
Patients who have previously taken statins
Patients with chronic ischemic heart disease that has required stenting or revascularization
Trial design
Treatments tested in this trial
- Simple coronary CT scan